OSIR Financial Facts
Income tax expense: 132KIncome from operations: 310K
See Full Income Statement
Accounts payable and accrued expenses: 9.58M
Other assets: 95K
See Full Balance Sheet
Osiris Therapeutics (OSIR) Earnings
|
Expand Research on OSIR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -60.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/15  |
 |
Q315 | -$0.02 | $0.06 | -$0.08 | $24.3M | $25.4M | N/A |  | | Details |
| 8/5/15 |
|
Q215 | $0.03 | $0.06 | -$0.03 | $23.7M | $23.6M | N/A | | | Details |
| 5/8/15 | Q115 | $0.04 | $0.00 | +$0.04 | $21M | $18.4M | N/A | | | Details | |
| 3/5/15 |
|
Q414 | $0.02 | $0.05 | -$0.03 | $19.5M | $18.53M | N/A | | | Details |
| 11/7/14 |
|
Q314 | $0.02 | -$0.01 | +$0.03 | $17.2M | $14.8M | N/A | | | Details |
| 8/7/14 | Q214 | -$0.04 | $0.16 | -$0.20 | $13.3M | $11M | N/A | | | Details | |
| 3/5/14 | Q413 | $0.11 | $0.65 | -$0.54 | $8.1M | $7.5M | N/A | | | Details | |
| 11/1/13 |
|
Q313 | -$0.05 | -$0.10 | +$0.05 | $6.88M | $6.7M | N/A | | | Details |
